Meeder Asset Management’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$21.9K	Hold	984	–	–	﹤0.01%	552
2025 Q4	$26.3K	Buy	+984	New	+$23.5K	﹤0.01%	492
2025 Q2	–	Sell	-26,960	Closed	-$448K	–	850
2025 Q1	$448K	Buy	+26,960	New	+$490K	0.03%	184
2021 Q4	–	Sell	-24	Closed	–	–	1095
2021 Q3	$0	Hold	24	–	–	﹤0.01%	2461
2021 Q2	$1K	Hold	24	–	–	﹤0.01%	2295
2021 Q1	$1K	Sell	24 -43	-64%	-$1.89K	﹤0.01%	2162
2020 Q4	$4K	Sell	67 -9	-12%	-$447	﹤0.01%	1252
2020 Q3	$3K	Sell	76 -36	-32%	-$1.55K	﹤0.01%	1697
2020 Q2	$5K	Sell	112 -3,133	-97%	-$150K	﹤0.01%	1500
2020 Q1	$136K	Sell	3,245 -3,066	-49%	-$126K	0.01%	648
2019 Q4	$271K	Buy	6,311 +135	+2%	+$5.87K	0.02%	520
2019 Q3	$221K	Buy	6,176 +5,889	+2,052%	+$179K	0.01%	583
2019 Q2	$8K	Sell	287 -723	-72%	-$18.5K	﹤0.01%	1510
2019 Q1	$27K	Sell	1,010 -2,599	-72%	-$60.7K	﹤0.01%	998
2018 Q4	$57K	Buy	3,609 +3,336	+1,222%	+$64.8K	0.01%	776
2018 Q3	$6K	Buy	+273	New	+$4.29K	﹤0.01%	1278
2018 Q2	–	Sell	-124	Closed	-$3K	–	1544
2018 Q1	$3K	Hold	124	–	–	﹤0.01%	1311
2017 Q4	$4K	Buy	+124	New	+$3.96K	﹤0.01%	1347